?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
Biosimilars Forum
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
February 26, 2019
Biosimilars Forum
Removing 340B Pass-Through Would be Detrimental to US Healthcare Savings
News
February 26, 2019
Biosimilars Forum
The Biosimilars Forum Urges Senate Finance Committee to Seek Meaningful Biosimilars Reform
News
February 12, 2019
Biosimilars Forum
The Biosimilars Forum Objects to Consolidate Billing of Biosimilars
News
February 1, 2019
Biosimilars Forum
The Biosimilar Forum Recognizes Leah Christl’s Departure from FDA
News
January 31, 2019
Biosimilars Forum
The Biosimilars Forum Applauds HHS Proposal to Target Costly Rebates Structure Blocking Patients from Biosimilars and Savings
News
December 13, 2018
Biosimilars Forum
The Biosimilars Forum Commends FDA for Commitment to Increase Patient Access to Biosimilars
News
December 4, 2018
Biosimilars Forum
Biosimilars Forum Statement on Citizen Petition to the Food and Drug Administration
News
December 3, 2018
Biosimilars Forum
Biosimilars Forum Announces Launch of Biosimilars Roundtable
News
October 10, 2018
Biosimilars Forum
New White Paper Finds Biosimilars Could Drive Greater Value Beyond Price for Healthcare System
News
August 9, 2018
Biosimilars Forum
Biosimilars Forum Statement on CMS Announcement Regarding Medicare Advantage
Prev page
01
02
03
04
05
Next page